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Aerolysin is a major virulence factor produced by the Gram-negative bacterium
Aeromonas hydrophila and is a member of the -pore-forming toxin family. Two
oligomerization-deficient aerolysin mutants, H132D and H132N, have been
overproduced, proteolyzed by trypsin digestion and purified. Crystals were
grown from the proteolyzed forms and diffraction data were collected for the
two mutants to 2.1 and 2.3 A˚ resolution, respectively. The prism-shaped crystals
belonged to space group C2. The crystal structure of the mutants in the mature,
but not heptameric, aerolysin form will provide insight into the intermediate
states in the oligomerization process of a pore-forming toxin.
1. Introduction
Aerolysin is a major virulence factor produced by the Gram-negative
bacterium Aeromonas hydrophila, which induces gastrointestinal
infections with diarrhoea as well as deep-wound infections in humans
(Abrami et al., 2000; Aroian & van der Goot, 2007). It belongs to the
largest group of well characterized bacterial toxins, i.e. the -pore-
forming toxins (Iacovache et al., 2008, 2010; Parker & Feil, 2005). The
toxin is secreted by the bacterium into the extracellular medium via
a type II secretion system as proaerolysin, an inactive water-soluble
precursor of 470 amino acids. The structure of proaerolysin as a
dimer, which has been solved by X-ray crystallography to a resolution
of 2.8 A˚ (PDB entry 1pre; Parker et al., 1994), reveals that it is an
L-shaped molecule formed by a small N-terminal domain and an
elongated lobe divided into three structural domains. Proaerolysin
interacts with target cells by binding specifically to glycosylphos-
phatidylinositol-anchored proteins (GPI-APs) that act as receptors
(Fivaz et al., 2001). The toxin binds to its receptor via two distinct
binding sites: to the glycan core of the GPI anchor and to the
N-linked sugar of the protein moiety of the receptor (Hong et al.,
2002; Diep et al., 1998).
Proaerolysin is processed into an activated form, aerolysin,
following proteolysis in the C-terminal extremity of the protein
between residues 420 and 430 encompassing the cleavage site (van
der Goot et al., 1992). This proteolysis can be achieved by proteases
produced either by the bacterium itself, enzymes of the digestive tract
such as trypsin or chymotrypsin, or by cell-surface-associated
proteases such as furin (Abrami et al., 1998; Howard & Buckley,
1985). Previous studies using proaerolysin point mutants and fluor-
escence energy transfer indicated that a carboxy-terminal propeptide
(CTP) composed of 43 residues is released from the body of the toxin
and does not participate in subsequent formation of the transmem-
brane channel (van der Goot et al., 1994). However, biochemical
studies on the related toxin Clostridium septicum -toxin indicated
that the CTP remains bound to the mature protein and is only
displaced during the oligomerization process (Sellman & Tweten,
1997).
Mature aerolysin oligomerizes into a ring-like heptamer (Wilmsen
et al., 1991; Moniatte et al., 1996). During heptamerization, all of the
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monomers bring together an amphipathic -hairpin to form a
-barrel, the exterior of which is hydrophobic. Owing to the exposure
of hydrophobic regions, the aerolysin heptamer then spontaneously
inserts into the lipid bilayer of the membrane to create a trans-
membrane channel. Heptamerization requires a high local toxin
concentration, which is achieved by binding to receptors on the cell
surface and subsequent localization in specific membrane domains
(Abrami & van der Goot, 1999).
The histidine residue at position 132 located in domain 2 has been
shown to be essential in the initiation of oligomerization. Indeed,
substitution of His132 by an asparagine or an aspartate prevents
oligomerization of the toxin (Green & Buckley, 1990; Wilmsen et al.,
1991; Cabiaux et al., 1997). Further investigations confirmed that the
protonation state of His132 is crucial for oligomerization to occur
(Buckley et al., 1995).
Membrane insertion of aerolysin leads to permeabilization of the
plasma membrane and ultimately induces the death of target cells
(Gurcel et al., 2006). In domain 3 of the toxin, we identified a loop
that contains an alternating pattern of charged and uncharged resi-
dues lining the transmembrane channel (Iacovache et al., 2006;
Rossjohn et al., 1998). The tip of this loop is composed of a stretch of
five hydrophobic residues. We have shown that this hydrophobic turn
drives membrane insertion and, once it has crossed the membrane,
folds in a rivet-like fashion (Iacovache et al., 2006). These recent
findings challenge a previously proposed model in which domain 4
lines the channel and raise the possibility that this domain undergoes
a major conformational change upon proteolytic activation of the
precursor and/or heptamerization.
While the structure of dimeric proaerolysin is known at high
resolution (Parker et al., 1994) and that of the aerolysin heptamer
is known at low (13 A˚) resolution (Tsitrin et al., 2002), information
regarding nonheptameric aerolysin is lacking. Structural studies are
hampered by the fact that this species is transient, especially at the
high concentrations that would be required to induce crystallization.
To circumvent this difficulty, we decided to take advantage of the
fact that the two mutants H132N and H132D are oligomerization-
deficient in order to gain access to the activated aerolysin structure,
possibly in its monomeric state. Here, we report the purification,
crystallization and preliminary X-ray data analysis of the oligomer-
ization-deficient mutants H132N and H132D in their proteolyzed
forms. This is the first time that an intermediate in the oligomeriza-
tion process of pore-forming toxins has been studied by X-ray
crystallography and the outcome should provide insight into the
changes that prime the toxin for oligomerization.
2. Experimental procedure
2.1. Plasmid preparation and protein overproduction and
purification
The pET22b(+):aerA plasmid expressing wild-type proaerolysin
from residue Ala1 to residue Gln470 with a tail of six histidine resi-
dues at the C-terminus was used as a starting matrix DNA (Iacovache
et al., 2006). Site-directed mutagenesis was performed using the
QuikChange Kit (Stratagene). The primer 50-TGG GTG GGC GGC
AAT GAC AGC CAA TAT GTC GGC-30 and its reverse comple-
ment were used to create the pET22b(+):aerA-H132D plasmid. The
introduction of the expected mutation was confirmed by DNA
sequencing. The pET22b(+):aerA-H132N plasmid had previously
been prepared. Escherichia coli strain BL21 (DE3) was transformed
separately with the two plasmids in order to overproduce the two
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Figure 1
12% SDS–PAGE analysis of trypsin proteolysis of the aerolysin mutant H132N.
Lane 1, molecular-mass markers (sizes are indicated in kDa). Lane 2, H132N before
proteolysis. Lane 3, proteolyzed H132N after trypsin proteolysis. Lane 4, after
addition of the trypsin inhibitor and overnight dialysis at 277 K: the proteolyzed
H132N was concentrated before loading onto the gel-filtration column.
Figure 3
Determination of the expected association state of the proteolyzed H132N mutant.
The calibration curve of the gel-filtration column was produced using blue dextran
(used to determined a void volume of V0 = 8.9 ml); catalase (232 kDa), BSA
(66 kDa) and lysozyme (14.3 kDa) were used as standards (blue diamonds). The
elution volumes (Ve) of the proteolyzed H132N mutant (magenta square) and wild-
type proaerolysin (green triangle) were expressed as relative values (Ve/V0) and are
reported on the graph. Both samples were injected four times. Using their
theoretical molecular masses, the aerolysin wild-type dimer (94.8 kDa; orange filled
circle) and the aerolysin heptamer (331.8 kDa; red circle) are reported on the graph
for comparison.
Figure 2
Gel-filtration chromatogram of the proteolysed mutant H132N.
point mutants in the periplasmic compartment of the bacteria as
C-terminally His-tagged proteins.
For both mutants, the same protocol was applied for over-
production and purification. One isolated colony was picked and
allowed to grow in Luria–Bertani medium supplemented with
ampicillin (100 mg ml1) at 310 K under 220 rev min1 agitation. The
saturated overnight culture was diluted in fresh LB medium and
grown for 2.5 h at 310 K with shaking. Protein overproduction was
induced by addition of 1 mM isopropyl -d-1-thiogalactopyranoside
when the culture reached an OD600 nm of 0.6–0.8 and was allowed to
proceed at 295–298 K for 3 h. Bacteria were harvested by centrifu-
gation at 4000 rev min1. In order to release the periplasmic fraction
by osmotic shock, the pelleted bacteria were resuspended in a sucrose
shock solution consisting of 20 mM Tris–HCl pH 8, 5 mM EDTA,
20% sucrose, to which lyzozyme was added to a final concentration of
0.1 mg ml1, and left on ice for 45 min. The suspension was clarified
by centrifugation at 10 000 rev min1 for 15 min at 277 K and the
supernatant was recovered and dialysed overnight at 277 K against a
buffer consisting of 20 mM sodium phosphate pH 7.4, 0.5M NaCl.
The recovered fraction was then loaded onto a Sepharose nickel-
affinity chromatography column. The mutant was eluted using a
gradient with an increasing proportion of a buffer containing 20 mM
sodium phosphate pH 7.4, 0.5M NaCl and 0.5M imidazole. The
mutant eluted at 55% of the gradient.
The eluted fraction containing the protein was dialysed overnight
at 277 K in a buffer consisting of 20 mM Tris–HCl pH 8, 150 mM
NaCl. Once recovered, the protein was brought to a concentration of
0.8 mg ml1 and submitted to proteolysis. The concentration of the
protein solution was determined by measuring the optical density at
280 nm, considering that a 1 mg ml1 sample has an OD of 2.5 (van
der Goot et al., 1994). For the proteolysis step, soluble trypsin at
1 mg ml1 was added to the protein solution at a mass ratio of 1:400.
The digestion was performed at room temperature for 45 min. The
proteolysis reaction was stopped by adding a trypsin–chymotrypsin
inhibitor to the mixture to a concentration of 10 mg ml1 and incu-
bating for 30 min at room temperature. The digested protein was then
dialyzed overnight at 277 K in the buffer (20 mM HEPES pH 7.4,
150 mM NaCl) usually used for oligomerization of the toxin.
At each step, a small amount of the sample was picked up and
loaded onto an SDS–polyacrylamide gel to check whether the
heptamer was formed. Indeed, formation of the aerolysin heptamer
can be monitored by an SDS–PAGE analysis run under denaturing
conditions because aerolysin heptamers are very stable and can
withstand boiling in the sample buffer containing sodium dodecyl
sulfate and the reducing agent -mercaptoethanol (Garland &
Buckley, 1988; Lesieur et al., 1999; Tsitrin et al., 2002). Under dena-
turing conditions, the aerolysin heptamer migrates in the gel with an
apparent molecular mass of 333 kDa (Garland & Buckley, 1988;
crystallization communications
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Figure 4
Crystallization trials for the H132N and H132D mutants. (a) One single hit was found for H132N with the condition 35%(v/v) 5/4 PO/OH, 50 mMHEPES pH 7.5, 0.2MKCl.
(b) The same crystallization condition with a different buffer, 50 mM sodium acetate pH 5.4, was tested with H132D and sea urchin-like crystals appeared. (c) The removal of
KCl allowed single crystals of H132D to appear. (d) Final crystallization condition for H132D: 19%(v/v) 5/4 PO/OH, 50 mM sodium acetate pH 5.4.
Lesieur et al., 1999) and the corresponding band usually appears at
the top of the gel. The digestion of the mutant was complete and the
oligomerization following activation did not occur (Fig. 1). The
proteolyzed protein was further purified by gel filtration, each time
loading about 0.5 ml at a concentration of 5 mg ml1 onto a Superdex
200 10/300 GL column (GE Healthcare) running at 0.5 ml min1 in
20 mM HEPES pH 7.4, 150 mM NaCl. After this last step of purifi-
cation, the recovered sample was homogenous and was eluted with an
elution volume of 15 ml (Fig. 2), which corresponds to an apparent
molecular mass of 116 kDa (Fig. 3). Taking into account that the
theoretical molecular mass of the activated aerolysin wild-type dimer
is 94.8 kDa, it is expected that the proteolyzed mutant H132N is
associated as a dimer (Fig. 3). Finally, at the end of the last purifi-
cation step by gel filtration, five 1 ml fractions containing the protein
were collected and concentrated by centrifugation in a 30 kDa
molecular-mass cutoff Vivaspin centrifugal concentrator (Viva-
science, Sartorius Group) to a concentration of 5 mg ml1 at 277 K.
2.2. Crystallization
Crystallization trials were carried out by sparse-matrix screening
(Jancarik et al., 1991) at 291 K using the hanging-drop vapour-
diffusion technique. 2 ml drops were prepared by mixing equal
volumes of protein solution and reservoir solution and were equili-
brated against 500 ml reservoir solution. For the first round of crys-
tallization trials, the proteolyzed H132N protein (5 mg ml1 in 20 mM
HEPES pH 7.4, 150 mM NaCl) was screened against various condi-
tions: those in which wild-type proaerolysin crystals appeared
(Parker et al., 1994) and conditions from several crystallization
screening kits such as Crystal Screen, Crystal Screen 2 and Index
Screen (Hampton Research, USA). Precipitates appeared in most of
the drops. A unique first hint was identified with condition No. 56
of Hampton Research Index Screen [35%(v/v) pentaerythritol
propoxylate (5/4 PO/OH), 0.05M HEPES pH 7.5, 0.2M potassium
chloride], in which initial crystal germs appeared after two weeks
(Fig. 4a).
Optimization experiments were set up manually (by testing several
buffer solutions with various pH ranges and different concentrations
of KCl) and were performed on the proteolyzed H132D protein
(Figs. 4b and 4c). Finally, H132D crystals suitable for X-ray diffrac-
tion experiments grew within one week in 17–19% 5/4 PO/OH,
50 mM sodium acetate pH 5.4 (Fig. 4d). H132N crystals grew in a
similar solution in which the concentration of 5/4 PO/OH was
increased to 24–28%.
2.3. Data collection and processing
Diffraction data were recorded at 100 K. Prior to data collection,
crystals were briefly immersed in a cryoprotectant solution with the
same composition as the mother liquor but with an increase in the
concentration of 5/4 PO/OH (to 30% for H132D crystals and 32% for
H132N crystals). After this rapid immersion, the crystals were flash-
cooled by plunging them into liquid nitrogen. In this case, 5/4 PO/OH
could not only be used as a crystallization agent but also as a cryo-
protectant (Gulick et al., 2002). X-ray diffraction data sets for the two
aerolysin mutants H132D and H132N were collected on beamline
X06SA at the Swiss Light Source, Villigen, Switzerland equipped with
a MAR CCD detector and tuned to a wavelength of 0.9536 A˚. Each
data set was obtained from a single crystal and more than 360 of data
were recorded. A typical diffraction pattern recorded using a H132D
crystal is shown in Fig. 5. Raw diffraction images were indexed and
integrated with MOSFLM (Leslie, 2006) and scaled with SCALA
(Evans, 2006) within the CCP4 program suite (Collaborative Com-
putational Project, Number 4, 1994). Relevant statistics are given in
Table 1.
3. Results and discussion
We have crystallized two oligomerization-deficient mutants of aero-
lysin, H132D and H132N, in their proteolyzed forms. The prism-
shaped crystals of both mutants belonged to space group C2 and have
fairly similar unit-cell parameters (a = 95.72, b = 70.21, c = 165.44 A˚,
 = 109.11 for H132D and a = 95.98, b = 69.31, c = 165.23 A˚,
 = 109.01 for H132N), suggesting that they are isomorphous.
However, the crystals of the two mutants are different from the
known wild-type crystal form, which belongs to space group P43212
(Parker et al., 1994). With a molecular mass of 47.4 kDa per
monomer, a reasonable value of the Matthews coefficient VM
(Matthews, 1968) was obtained for two monomers in the asymmetric
crystallization communications
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Figure 5
A diffraction image (1 rotation) recorded on the H132D aerolysin mutant crystal.
Table 1
X-ray diffraction data-collection parameters and statistics.
Values in parentheses are for the highest resolution shell.
H132D H132N
Space group C2 C2
Unit-cell parameters
a (A˚) 95.72 95.98
b (A˚) 70.21 69.31
c (A˚) 165.44 165.23
 () 109.11 109.01
Resolution limits (A˚) 56.0–2.1 (2.21–2.10) 56.0–2.3 (2.42–2.30)
No. of measured reflections 1270180 239594
Unique reflections 59799 43658
Completeness (%) 98.6 (97.8) 95.4 (74.7)
Multiplicity 21.2 (10.4) 5.5 (5.0)
Rmerge† (%) 8.8 (40.5) 7.5 (39.6)
hI/(I)i 24.5 (3.1) 16.3 (3.7)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) represents the ith
measurement of the intensity of the hkl reflection and its symmetry equivalent and
hI(hkl)i is the average intensity of the hkl reflection.
unit (VM = 2.77 A˚
3 Da1). This value is in the normal range for
globular proteins and corresponds to a solvent content of 56%. This
analysis confirms that even at the high concentrations required for
crystallization the mutants remain nonheptameric after proteolytic
processing.
Attempts to solve the structures of the two proteolyzed mutants by
molecular replacement are currently under way.
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